Nike : Julius “Dr. J” Erving Talks Basketball Style
September 21, 2017 at 02:11 am EDT
Share
In 1949, virtually every player in the newly minted National Basketball Association wore the Converse Chuck Taylor All Star. Around that time, future NBA legend Julius 'Dr. J' Erving was born. He might be famous for dunking from the foul line and rocking the Converse Pro Leather, but the Chuck Taylor is cemented in his childhood memories.
'I know in my first look at basketball on TV, I saw my favorite player's wearing Chuck Taylors. That was the shoe to get,' Erving explains. 'When you see people who you admire, people who you idolize, you look at them from head to toe…what they have on their feet is big.'
That legacy drives the Converse NBAcollection. Launching September 29, the collection represents all 30 NBA teams through three articulations of the NBA Chuck Taylor All Star: Gameday, Legend, and Franchise.
Nike Inc. published this content on 20 September 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 21 September 2017 06:09:04 UTC.
Original documenthttps://news.nike.com/news/converse-nba-collection
Public permalinkhttp://www.publicnow.com/view/BD99FC2E2D349219A04739869E00EF061F62BFC9
Nike, Inc. specializes in the design, manufacturing and marketing of sports shoes, clothing, and equipment. The group's products are sold primarily under the names Nike, Jordan, Converse Chuck Taylor, All Star, One Star, Star Chevron and Jack Purcell. Net sales break down by family of products as follows:
- footwear (68.9%);
- clothing (27.2%);
- sports equipment (3.4%): golf equipment (golf clubs, balls, gloves, etc.), bags, balls, etc.;
- other (0.5%).
At the end of May 2023, products were being marketed through a network of 1,032 stores worldwide, through independent distributors, and via the Internet.
Net sales are distributed geographically as follows: North America (44.3%), Europe/Middle East/Africa (27.5%), China (14.9%), Asia/Pacific and Latin America (13.2%) and other (0.1%).